(Q70191185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Phase II clinical and pharmacological study of oral 4-demethoxydaunorubicin in advanced non-pretreated small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference

R Milroy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

J Cummings

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S B Kaye

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

S W Banham

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

9 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

75-77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00252964

9 October 2019

exact match

0 references

cites work

Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study

1 reference

12 December 2020

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

12 December 2020

Phase-II trial of 4-demethoxydaunorubicin (DMDR) for advanced hypernephroma

1 reference

12 December 2020

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

12 December 2020

Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography

1 reference

12 December 2020

Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract

1 reference

12 December 2020

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

1 reference

12 December 2020

4-Demethoxydaunorubicin (Idarubicin) in refractory or relapsed acute leukemias. A pilot study.

1 reference

12 December 2020

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer

1 reference

12 December 2020

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00252964

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3040287%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference